|
New Data from Phase III IMPRES Clinical Trial
|
26 September 2011 |
|
Novartis associates participate in first company-wide health and well-being initiative
|
20 September 2011 |
|
Novartis increases growth potential through integration of Alcon
|
13 September 2011 |
|
Novartis drug Afinitor® gains EU approval to treat patients with advanced pancreatic neuroendocrine tumors
|
05 September 2011 |
|
Novartis delivers strong financial results and four major approvals
|
20 July 2011 |
|
Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers
|
18 July 2011 |
|
Phase III trial of Novartis drug Afinitor® met primary endpoint
|
08 July 2011 |
|
Novartis receives FDA approval for Arcapta(TM) Neohaler(TM)
|
04 July 2011 |
|
FDA panel endorses efficacy but not safety of Novartis drug ACZ885 for gouty arthritis
|
22 June 2011 |
|
Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia
|
17 June 2011 |